Imagion Biosystems announces change to Board of Directors.
Read the change to Board of Directors here.
Director Resignation — Dr. John Hazle
Highlights: Announced preliminary performance of MagSense® HER2 Imaging Agent in phase 1 study after study closure (post quarter end) Entered a strategic partnership with Prestige
Transforming medical imaging for early disease detection
We’re on a mission to make cancer more detectable.